体外受精妊娠间隔与单胎活产结局
该回顾性分析利用美国辅助生殖技术临床结局报告系统2004至2013年数据,纳入既往经辅助生殖技术活产并再次接受新鲜自体体外受精周期的患者,评估妊娠间隔与早产及低出生体重的关联。结果显示,与12至不足18个月相比,间隔不足6个月和6至不足12个月的早产调整比值比分别为1.66和1.34,间隔6至不足12个月与早产和低出生体重各增加约3%相关。
要点
- 与12至不足18个月相比,间隔不足6个月的单胎早产调整比值比为1.66(95%CI 1.05-2.65)。
- 间隔6至不足12个月与早产增加3.0%及低出生体重增加2.7%相关。
- 数据支持活产后推迟12个月开始体外受精,但不提示更长间隔有额外获益。
核心结论
- 在该全国代表性人群中,分娩至治疗开始间隔不足12个月与辅助生殖技术单胎活产的早产和低出生体重率升高相关。
- 数据支持活产后推迟12个月开始体外受精治疗,但不提示更长间隔有获益,与自然受孕夫妇推荐不同。
研究设计与样本
- 回顾性分析,使用美国辅助生殖技术临床结局报告系统2004至2013年数据。
- 队列为既往经辅助生殖技术活产并再次接受新鲜自体体外受精周期的患者,共51,997个周期。
- 妊娠间隔定义为活产至周期开始的时间,采用逻辑回归模型并调整年龄、体重指数和早产史。
主要发现
- 51,997个新鲜体外受精周期中,17,536个获得再次活产,其中11,271个为自体体外受精单胎活产。
- 妊娠间隔不足18个月者占40.9%。
- 与12至不足18个月相比,单胎早产调整比值比在间隔不足6个月为1.66(95%CI 1.05-2.65),在6至不足12个月为1.34(95%CI 1.06-1.69)。
- 与12至不足18个月相比,间隔6至不足12个月与早产增加3.0%(13.6±1.1% vs 10.6±0.7%,P=.030)和低出生体重增加2.7%(8.0±0.9% vs 5.3±0.5%,P=.025)相关。
临床怎么用
- 作者认为数据支持活产后推迟12个月开始体外受精治疗,但不提示更长间隔有获益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the relationship between a short interpregnancy interval and adverse pregnancy outcomes in the population undergoing assisted reproductive technology. METHODS: This is a retrospective analysis using data from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System. The cohort includes patients with a history of live birth from assisted reproductive technology who returned for a fresh, autologous in vitro fertilization (IVF) cycle from 2004 to 2013. Interpregnancy interval was defined as the interval from live birth to cycle start. Logistic regression models of preterm delivery (less than 37 weeks of gestation) and low birth weight (less than 2,500 g) on interpregnancy interval were fit with adjustment for age, body mass index, and history of preterm delivery. Predicted probabilities were generated from the logistic model. RESULTS: Of 51,997 fresh IVF cycles after an index live birth, 17,536 resulted in a repeat live birth with 11,271 singleton live births from autologous IVF. An interpregnancy interval of less than 18 months occurred in 40.9% of cycles. Compared with a reference interpregnancy interval of 12 to less than 18 months, the adjusted odds ratio for singleton preterm delivery was 1.66 (95% CI 1.05-2.65) for an interpregnancy interval less than 6 months and 1.34 (95% CI 1.06-1.69) for 6 to less than 12 months. An interpregnancy interval 6 to less than 12 months was associated with a 3.0% increase in preterm delivery (13.6±1.1% vs 10.6±0.7%, P=.030) and a 2.7% increase in low birth weight (8.0±0.9% vs 5.3±0.5%, P=.025) compared with an interpregnancy interval of 12 to less than 18 months. CONCLUSION: In this nationally representative population, an interval from delivery to treatment start of less than 12 months is associated with increased rates of preterm delivery and low birth weight in singleton live births from assisted reproductive technology. The data support delaying the start of IVF treatment 12 months from a live birth, but do not suggest a benefit from a longer interval as has been recommended for naturally conceiving couples.
引用
- Quinn MM, Rosen MP, Huddleston HG, et al. Interpregnancy Interval and Singleton Live Birth Outcomes From In Vitro Fertilization. Obstet Gynecol. 2018. PMID: 29889753. doi:10.1097/AOG.0000000000002644
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。